SEAS: Simvastatin and EZETimibe in aortic stenosis
principal researchers
Terje Pedersen (University of Oslo)
DATA CUSTODIAN
Merck & Co. Inc
FUNDING
Merck & Co. Inc.
key publications
- Design and baseline characteristics: Am J Cardiol 2007;99:970 –973
- Main results: N Engl J Med 2008;359:1343-56
- Analyses of Cancer Data from Three Ezetimibe Trials: N Engl J Med 2008;359:1357-66
- Observed and predicted reduction in CV events: Am J Cardiol 2010; 105(12):1802-8
- Impact of baseline severity of aortic stenosis: Am J Cardiol 2010; 106(11):1634-9
- Prognostic importance of atrial fibrillation: Int J Cardiol 2013; 166(1): 72-6
- Incidence of cancer and mortality: Am J Cardiol 2014; 114(10): 1518-22
- Effect on cataract: Am J Cardiol 2015; 166(12): 1840-4